Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.020
+0.060 (3.06%)
May 23, 2025, 4:00 PM - Market closed
CELZ Market Cap
CELZ has a market cap or net worth of $237.03 million as of May 23, 2025. Its market cap has increased by 3,850.45% in one year.
Market Cap
237.03M
Enterprise Value
229.34M
1-Year Change
3,850.45%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since December 11, 2017, CELZ's market cap has increased from $2.70M to $237.03M, an increase of 8,678.79%. That is a compound annual growth rate of 82.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 5.20M | 30.00% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | 0.63% |
| Dec 31, 2020 | 16.00M | 2,185.71% |
| Dec 31, 2019 | 700.00K | -91.03% |
| Dec 31, 2018 | 7.80M | 457.14% |
| Dec 29, 2017 | 1.40M | -48.15% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.81B |
| Johnson & Johnson | 368.56B |
| AbbVie | 321.13B |
| Novo Nordisk | 308.07B |
| UnitedHealth Group | 274.85B |
| Abbott Laboratories | 231.49B |
| Novartis AG | 222.59B |
| AstraZeneca | 218.71B |